Algernon Pharmaceuticals Inc.
AGNPFOTCHealthcare● Active
$0.44
+$0.01(+1.36%)
Market Cap$1541620
P/E Ratio—
52W High$0.713
52W Low$0.23
Algernon Pharmaceuticals Inc.（AGNPF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AGNPF · 截至 2026-06-15
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-08 | 2024-08 | 2023-08 | 2022-08 | 2021-08 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.00B) | $0.00B | $0.00B | ($0.00B) |
| Net Cash from Operations | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.01B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | $0.00B | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.01B) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · CAD · B
深入了解Algernon Pharmaceuticals Inc.
关于Algernon Pharmaceuticals Inc.（AGNPF）现金流量表
Algernon Pharmaceuticals Inc. 2025财年经营活动现金流($0.00B)，自由现金流($0.00B)（FCF利润率—），资本支出($0.00B)。
常见问题
AGNPF · 4 问Algernon Pharmaceuticals Inc. 2025财年自由现金流($0.00B)，同比up58.6%。
AGNPF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15